SCHEMBL4593930

SCHEMBL4593930

C=CC(=O)Nc1ccc2cncnc2c1

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ IMPDH2 P12268 1/20 0.57
▸ EGFR P00533 8/20 0.55
▸ BAZ1A Q9NRL2 1/20 0.54
▸ FYN P06241 7/20 0.51
▸ SRC P12931 7/20 0.51
▸ NOTUM Q6P988 1/20 0.51
▸ PRMT3 O60678 1/20 0.50
▸ ERBB2 P04626 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ VCP P55072 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3126931 0.89 AR (0.55) EGFRFYNSRCERBB2JAK3
SCHEMBL24151660 0.86 JAK3 (0.58) IMPDH2FYNSRCJAK3VCP
SCHEMBL30190528 0.86 JAK3 (0.58) IMPDH2FYNSRCJAK3VCP
SCHEMBL24150335 0.84 JAK3 (0.47) IMPDH2EGFRBAZ1AFYNSRC
SCHEMBL30190618 0.81 MAP4K4 (0.44) IMPDH2FYNSRCJAK3VCP
SCHEMBL24150841 0.81 MAP4K4 (0.44) IMPDH2FYNSRCJAK3VCP
SCHEMBL24150229 0.78 PLCG1 (0.44) IMPDH2EGFRBAZ1AFYNSRC
SCHEMBL24151659 0.77 FGFR4 (0.46) IMPDH2FYNSRCNOTUMJAK3
SCHEMBL31036070 0.75 NOTUM (0.61) IMPDH2EGFRBAZ1ANOTUMPRMT3
SCHEMBL28145788 0.74 EGFR (0.63) IMPDH2EGFRBAZ1ANOTUMPRMT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016010961-A1 ENZYME OCCUPANCY ASSAY ABBVIE INC. (US) 2016-01-21 — — WO disclosed
EP-1579186-A4 IDENTIFICATION OF KINASE INHIBITORS SUNESIS PHARMACEUTICALS INC (US) 2008-10-08 — — EP disclosed
US-7202033-B2 Identification of kinase inhibitors SUNESIS PHARMACEUTICALS, INC. (US) 2007-04-10 — — US disclosed
EP-1579186-A2 IDENTIFICATION OF KINASE INHIBITORS Sunesis Pharmaceuticals, Inc. (US) 2005-09-28 — — EP disclosed
US-20030232391-A1 Identification of kinase inhibitors SUNESIS PHARMACEUTICALS, INC. 2003-12-18 — — US disclosed
WO-2003081210-A2 IDENTIFICATION OF KINASE INHIBITORS SUNESIS PHARMACEUTICALS, INC. (US) 2003-10-02 — — WO disclosed
Send feedback